IN2012DN05072A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN05072A IN2012DN05072A IN5072DEN2012A IN2012DN05072A IN 2012DN05072 A IN2012DN05072 A IN 2012DN05072A IN 5072DEN2012 A IN5072DEN2012 A IN 5072DEN2012A IN 2012DN05072 A IN2012DN05072 A IN 2012DN05072A
- Authority
- IN
- India
- Prior art keywords
- fluoroalkyl
- sulfonate esters
- iodides
- labelledra
- diopharmaceutical
- Prior art date
Links
- -1 fluoroalkyl iodides Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 125000001273 sulfonato group Chemical class [O-]S(*)(=O)=O 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 abstract 1
- 229930004006 tropane Natural products 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/06—Halogens; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Abstract
The present invention relates to an improved synthesis of N-monofluoroalkyl tropanes using fluoroalkyl iodides or fluoroalkyl sulfonate esters. The invention also provides the use of such method to prepare the non-radioactive tropane intermediate FP-CIT, and its subsequent conversion to the '23~-labelledra diopharmaceutical D ~ T S C A N ~ ~ (1231-ioflupane). Also provided is the use of fluoroalkyl iodides or fluoroalkyl 10 sulfonate esters in the alkylation method of the invention.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28726409P | 2009-12-17 | 2009-12-17 | |
| GBGB0922023.7A GB0922023D0 (en) | 2009-12-17 | 2009-12-17 | Preparation of n-monofluoroalkyl compounds |
| PCT/EP2010/069758 WO2011073256A1 (en) | 2009-12-17 | 2010-12-15 | Preparation of n-monofluoroalkyl tropanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN05072A true IN2012DN05072A (en) | 2015-10-09 |
Family
ID=41717082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5072DEN2012 IN2012DN05072A (en) | 2009-12-17 | 2010-12-15 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120244072A1 (en) |
| EP (1) | EP2513099B1 (en) |
| JP (1) | JP5806680B2 (en) |
| KR (1) | KR101757950B1 (en) |
| CN (2) | CN106977510B (en) |
| AU (1) | AU2010332895B2 (en) |
| BR (1) | BR112012014357B8 (en) |
| CA (1) | CA2782945C (en) |
| ES (1) | ES2761931T3 (en) |
| GB (1) | GB0922023D0 (en) |
| IN (1) | IN2012DN05072A (en) |
| MX (1) | MX339670B (en) |
| PL (1) | PL2513099T3 (en) |
| RU (1) | RU2552355C2 (en) |
| WO (1) | WO2011073256A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2711122T3 (en) * | 2013-09-25 | 2019-04-30 | SpecGx LLC | Preparation of radioiodinated 3-fluoropropyl-nor-beta-CIT |
| JP7241013B2 (en) * | 2017-03-17 | 2023-03-16 | 日本メジフィジックス株式会社 | Production method of isoflurane |
| EP3880674A1 (en) | 2020-01-24 | 2021-09-22 | Rotop Radiopharmacy Gmbh | Method for the preparation of n-monofluoroalkyl tropanes and their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750089A (en) * | 1996-01-11 | 1998-05-12 | Neuro Imaging Technologies, Llc | Halogenated neuroprobe for mapping monoamine reuptake sites |
| EP0831941B1 (en) * | 1995-06-06 | 2012-04-04 | GE Healthcare Limited | Iodinated neuroprobes for mapping monoamine reuptake sites |
| EP1444990A1 (en) * | 2003-02-07 | 2004-08-11 | Amersham plc | Improved Radiometal Complex Compositions |
| KR100789847B1 (en) * | 2004-12-15 | 2007-12-28 | (주)퓨쳐켐 | A Preparation Method of Organo Fluoro Compounds in Alcohol Solvents |
-
2009
- 2009-12-17 GB GBGB0922023.7A patent/GB0922023D0/en not_active Ceased
-
2010
- 2010-12-15 CA CA2782945A patent/CA2782945C/en not_active Expired - Fee Related
- 2010-12-15 RU RU2012124263/04A patent/RU2552355C2/en active
- 2010-12-15 JP JP2012543720A patent/JP5806680B2/en active Active
- 2010-12-15 ES ES10794975T patent/ES2761931T3/en active Active
- 2010-12-15 BR BR112012014357A patent/BR112012014357B8/en active IP Right Grant
- 2010-12-15 PL PL10794975T patent/PL2513099T3/en unknown
- 2010-12-15 EP EP10794975.2A patent/EP2513099B1/en active Active
- 2010-12-15 CN CN201610954526.2A patent/CN106977510B/en active Active
- 2010-12-15 IN IN5072DEN2012 patent/IN2012DN05072A/en unknown
- 2010-12-15 CN CN2010800571169A patent/CN102781938A/en active Pending
- 2010-12-15 KR KR1020127015454A patent/KR101757950B1/en active IP Right Grant
- 2010-12-15 WO PCT/EP2010/069758 patent/WO2011073256A1/en active Application Filing
- 2010-12-15 US US13/514,074 patent/US20120244072A1/en not_active Abandoned
- 2010-12-15 MX MX2012007038A patent/MX339670B/en active IP Right Grant
- 2010-12-15 AU AU2010332895A patent/AU2010332895B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101757950B1 (en) | 2017-07-13 |
| CA2782945A1 (en) | 2011-06-23 |
| KR20120107473A (en) | 2012-10-02 |
| PL2513099T3 (en) | 2020-06-29 |
| MX2012007038A (en) | 2012-07-20 |
| BR112012014357B8 (en) | 2021-07-27 |
| RU2012124263A (en) | 2014-01-27 |
| CA2782945C (en) | 2018-05-01 |
| US20120244072A1 (en) | 2012-09-27 |
| JP2013514314A (en) | 2013-04-25 |
| CN106977510B (en) | 2021-06-08 |
| BR112012014357A2 (en) | 2015-09-15 |
| CN102781938A (en) | 2012-11-14 |
| EP2513099B1 (en) | 2019-11-20 |
| GB0922023D0 (en) | 2010-02-03 |
| AU2010332895B2 (en) | 2015-05-21 |
| ES2761931T3 (en) | 2020-05-21 |
| WO2011073256A1 (en) | 2011-06-23 |
| BR112012014357B1 (en) | 2021-04-06 |
| MX339670B (en) | 2016-06-03 |
| RU2552355C2 (en) | 2015-06-10 |
| EP2513099A1 (en) | 2012-10-24 |
| JP5806680B2 (en) | 2015-11-10 |
| CN106977510A (en) | 2017-07-25 |
| AU2010332895A1 (en) | 2012-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500962A1 (en) | Novel european prrsv strain | |
| MY159312A (en) | Glass fiber | |
| WO2010111409A3 (en) | Pluripotent stem cells | |
| IN2014DN07024A (en) | ||
| MX2015002056A (en) | Geopolymer cement compositions and methods of use. | |
| SG10201805198TA (en) | 18f - fluciclovine compositions in citrate buffers | |
| MX2011012060A (en) | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide. | |
| IN2014DN03102A (en) | ||
| HK1125291A1 (en) | Method of using guava extract and composition including guava extract | |
| NZ600079A (en) | A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma | |
| IN2012DN00852A (en) | ||
| WO2014056713A3 (en) | Oral care composition | |
| MX2015005313A (en) | Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers. | |
| MX349684B (en) | Film containing compositions. | |
| MX2012010382A (en) | Modulating aquaporins with relaxin. | |
| IN2012DN05072A (en) | ||
| MX2010000979A (en) | Methods and compositions for treating autoimmune disease. | |
| MX2010005015A (en) | Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein. | |
| MY189261A (en) | A metal modified y zeolite, its preparation and use | |
| WO2011097527A3 (en) | Immunoprotection of therapeutic moieties using enhanced fc regions | |
| UA98698C2 (en) | Phenylsulfanylphenyl-piperidines and process for the preparation thereof | |
| IN2012DN03311A (en) | ||
| CN201654490U (en) | Wrist watch provided with compass | |
| MX354325B (en) | Method for preparing multiple antigen glycopeptide carbohydrate conjugates. | |
| EP2526422A4 (en) | Method of diagnosing sjogren's disease |